Showing results (11-20 of 17) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
American Journal of Physiology. Gastrointestinal and Liver Physiology|January 18, 2019
Defective FXR-FGF15 signaling and bile acid homeostasis in cystic fibrosis mice can be restored by the laxative polyethylene glycolAnna Bertolini, Ivo P van de Peppel, Marcela Doktorova-Demmin, et al.Diseases (Basel, Switzerland)|July 26, 2024
STRILL: Phase I Trial Evaluating Stereotactic Body Radiotherapy (SBRT) Dose Escalation for Re-Irradiation of Inoperable Peripheral Lung LesionsDavide Franceschini, Mauro Loi, Antonio Marco Marzo, et al.Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|September 29, 2023
Treatment of intestinal and liver features in cystic fibrosis mice by the osmotic laxative polyethylene glycolAnna Bertolini, Vincent W Bloks, Marijn Wilmink, et al.The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|July 8, 2025
Stereotactic body radiation therapy for the re-irradiation of local relapse from prostate cancer: results in terms of outcomes and toxicityCiro Franzese, Raffaella Lucchini, Marco Badalamenti, et al.Cancers|September 14, 2024
Predictive Factors for Long-Term Disease Control in Systemic Treatment-Naïve Oligorecurrent Renal Cell Carcinoma Treated with Up-Front Stereotactic Ablative Radiotherapy (SABR)Ciro Franzese, Veronica Vernier, Marco Badalamenti, et al.Current Oncology (Toronto, Ont.)|July 28, 2023
Can STEreotactic Body Radiation Therapy (SBRT) Improve the Prognosis of Unresectable Locally Advanced Pancreatic Cancer? Long-Term Clinical Outcomes, Toxicity and Prognostic Factors on 142 Patients (STEP Study)Tiziana Comito, Maria Massaro, Maria Ausilia Teriaca, et al.Scientific Reports|May 28, 2021
Potential of therapeutic bile acids in the treatment of neonatal HyperbilirubinemiaLori W E van der Schoor, Henkjan J Verkade, Anna Bertolini, et al.Pageof 2